News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Exenatide Has Potential as a Disease Modifying Agent in Parkinson`s Disease

(May 12, 2014) – Exenatide, a medication used in the treatment of insulin resistance in patients with Type 2 diabetes, has been proposed as a disease modifying drug for people living with Parkinson’s disease (PD). A follow-up study of patients with PD showed that improvements persisted twelve months after discontinuing exenatide therapy. Read more…